← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2016Last known activity
May 16, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 4 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT05939726Lead sponsorN/AMay 16, 2023
- NCT05939726Overall official - principal investigatorN/AMay 16, 2023
- NCT05939726Reponsible party - principal investigatorN/AMay 16, 2023
- NCT04654676CollaboratorPhase 4Sep 15, 2018
- NCT04654676Overall official - principal investigatorPhase 4Sep 15, 2018
- NCT03459599Overall official - principal investigatorN/AOct 1, 2016
- NCT03459599Lead sponsorN/AOct 1, 2016
- NCT03459599Reponsible party - principal investigatorN/AOct 1, 2016
- NCT02783859CollaboratorPhase 4Jun 1, 2016
Details
- Last known activity
- May 16, 2023